Health Professional Radio - Podcast

Robert Davidson, CEO of CURE Pharmaceutical, a drug delivery and development company discusses their delivery platform called CUREform™, which includes their signature oral film called CUREfilm® and how they were able to figure out RX dosage on thin films. This is a major gain for those who have problems taking traditional pills....especially in a hospital setting. He also talks about the recent Investigational New Drug (IND) approval by the FDA for their ED drug CUREfilmBlue™ and what's next in the pipeline. Robert Davidson is CURE's CEO. Prior to his role at CURE Pharmaceutical, Davidson served as President and CEO of InnoZen, Inc., CEO of Gel Tech LLC, CEO of Bio Delivery Technologies Inc, and served on multiple corporate boards. Mr. Davidson was responsible for the development of several drug delivery technologies and commercial brand extensions. He has worked with brands such as Chloraseptic, Suppress as well as Pedistrips, a private label electrolyte oral thin film sold in major drug store chains. M

Patients are delaying their health needs due to COVID-19. Dr. Jamie Rutland, Board-Certified Pulmonary and Critical Care Physician, discusses "My Health Can't Wait" an educational effort and resource hub launched by Johnson & Johnson Medical Devices Companies that provide patients and healthcare providers with tools to help them engage in meaningful conversations about prioritizing needed care, and offers tools such as patient outreach templates, surgery discussion checklists, and telehealth resources. Dr. Cedric “Jamie” Rutland, a Board Certified (Internal Medicine, Pulmonary, Critical Care) Pulmonary and Critical Care Physician based in Southern California, received his medical degree and completed his residency in Internal Medicine from the University of Iowa Carver College of Medicine in Iowa City, IA. Dr. J. Rutland continued his education at the University of Kansas Medical Center specializing in Pulmonary and Critical Care medicine. Dr. J. Rutland practices with Pacific Pulmonary Medical Group an

Dr. Michael Blackman, Chief Medical Officer at Greenway Health, a leading health information technology services provider, discusses navigating healthcare in 2021, how Greenway will further support its ambulatory care clients in the new year, major changes/updates regarding the 2021 Physician Fee Schedule, the role of interoperability in COVID-19 vaccine distribution, and more.

Returned guest, Dr. Richard Levitan, an airway specialist who has practiced emergency medicine for over 30 years, and co-founder and executive director of Prone2Help, a national 501c3 non-profit organization, discusses pulse oximetry and how it can help in the early diagnosis of COVID-19 because some patients with COVID don't experience respiratory distress even though their "xrays showed diffuse pneumonia and their oxygen was below normal." Dr. Richard Levitan was in the first class of Emergency Medicine residents at Bellevue Hospital (1990-1994), and subsequently worked in academic, high-volume, inner-city trauma hospitals in NYC and Philadelphia for 25 years (Bellevue, Lincoln, Penn, Einstein, Jefferson). Starting in 2012 he began working in rural, critical care access hospitals. He now balances this clinical activity with teaching courses, speaking engagements, and device development. In addition to the Airway Cam (1994), his inventions include the Levitan FPS optical stylet (Clarus Medical), the Contro

Dr. Eiman Shafa, MD, Orthopedic Surgery Specialist in Minneapolis, MN discusses his experience with Medtronic's navigated interbody, disc prep, and Midas Rex™ high-speed drills with the Mazor™ Robotic Guidance System. It allows surgeons to quickly visualize anatomy and spinal structures in relation to one another in 3D. Eiman Shafa, MD, FAAOS, is an Orthopedic Surgery Specialist in Minneapolis, MN. He currently works at Twin Cities Spine Center, where he performs minimally invasive and complex spine surgery and serves as director of education. In addition, he is the chair of robotic spine surgery and acting vice-chair of spine surgery and Allina Health. Dr. Shafa holds an M.D. from Temple University and completed his fellowship at Twin Cities Spine Center.

Judith Finlayson, bestselling author of "You Are What Your Grandparents Ate: What You Need to Know About Nutrition, Experience, Epigenetics & the Origins of Chronic Disease" discusses ways to slow down your epigenetic clock, how a Mediterranean Diet assists in reducing inflammation - in part, by positively influencing gene expression, mitigating predispositions toward chronic diseases, and teaching your children what to eat so that they are positively affecting their future children. She also talks about how the pandemic is affecting the way people are trying to take control of their health. Judith Finlayson is a bestselling author who has written books on a variety of subjects, from personal well-being and women's history to food and nutrition. A former national newspaper columnist for The Globe and Mail, magazine journalist, and board member of various organizations focusing on legal, medical, and women's issues, she is also the author of over a dozen cookbooks. Judith lives in Toronto, Canada. Judit

Barbara Marriage, Ph.D., R.D., nutrition science lead for pediatric nutrition at Abbott, discusses the immune system and how the right nutrition can go a long way to keeping us as healthy as possible. The scientists at Abbott have combined the advanced hydration of Pedialyte® with key nutrients to support the immune system in a convenient new powder product for both kids and adults called Pedialyte® with Immune Support. Barbara Marriage, Ph.D., RD, is a pediatric research dietitian and scientist with Abbott. She is a leading expert in genetic metabolic disorders. Over the years, she has conducted extensive global research in pediatric nutrition contributing to the development of nutrition therapies that help children with metabolic disorders get the nutrition they need to flourish. Barbara’s research interests include maternal nutrition, childhood obesity, and inborn errors of metabolism. Barbara has published over 25 articles in peer-reviewed journals, written book chapters, and newsletters, and has given

Dr. Dayna Long, Medical Director and Researcher, UCSF Benioff Children's Hospital, Oakland Center for Child and Community Health, discusses her involvement in the All In For Kids virtual series that took place in December 2020, and how research has shown that persistent childhood adversity – abuse, neglect, violence, racism, and other forms of trauma – can lead to higher rates of illness (cancer, stroke, Alzheimer’s, etc.) later in life. COVID-19 has exacerbated the trauma, isolation, and stress kids are experiencing and is disproportionately affecting Black, Latinx, Indigenous, and other communities of color. Dr. Dayna Long, Pediatrician, Medical Director and Researcher UCSF Benioff Children’s Hospital Oakland, Center for Child & Community Health. Dr. Dayna Long has been a primary care pediatrician at UCSF Benioff Children’s Hospital Oakland for over 20 years. For the past 5 years, she has also served as the co-Director of Center for Child and Community Health at University of California, San Francisco

Dr. Irene Ghobrial, MD, clinical investigator and senior physician at Dana-Farber Cancer Institute and Professor of Medicine at Harvard School of Medicine, discusses the partnering of the Dana-Farber Cancer Institute with Quest Diagnostics to identify the prevalence of COVID-19 in individuals with a precursor to multiple myeloma through the IMPACT study (Immune Profiling with Antibody-based COVID-19 Testing). She talks about how COVID 19 affects myeloma patients and various racial groups, and how the IMPACT study will play a role in the diagnostic recovery for this population. Dr. Ghobrial received her MD in 1995 from Cairo University School of Medicine, Egypt. She completed her Internal Medicine training at Wayne State University, Mich., and her Hematology/Oncology subspecialty training at Mayo Clinic College of Medicine, Minn. She joined Dana-Farber in the field of Waldenstrom's macroglobulinemia and multiple myeloma in 2005. She is conducting research in the area of homing and migration of B cells and

Dr. Jackie Walters, 2-time breast cancer survivor, OB/GYN, TV personality (Married To Medicine), bestselling author (The Queen of V), and podcast host (Power of V) discusses cervical cancer and the importance of potentially life-saving screenings for women – including those for cervical cancer – and why women should make sure to schedule an annual wellness exam in 2021. Philanthropist, health expert, women’s advocate, tv personality and award-winning OBGYN, Dr. Jacqueline Waters is on a mission to impact the lives of millions. “Dr. Jackie,” as she is affectionately known, graduated from the University of Mississippi and Alcorn State University, earning dual Bachelor of Science degrees. She later earned her medical degree from the University of Mississippi School of Medicine. In 1997, Dr. Jackie completed her residency in Obstetrics and Gynecology from the Medical Center of Central Georgia and Mercer University. After residency, she started in private practice where she became affiliated with Northside Hospi

Dr. Jeremy Horst, DDS, Director, Clinical Innovation for DentaQuest discusses dental health inequities and outlines some solutions to close the gap, ways to improve access to care in communities in need, and advancing policies to help make this possible. Jeremy Horst, DDS, PhD, Director, Clinical Innovation for DentaQuest. Jeremy leads the clinical innovation team at DentaQuest, advancing the clinical vision for the future of oral health by embracing advancements in person-centered care, technology, innovative diagnostic and preventive methods, targeted therapeutics, medical-dental integration and data science. Jeremy is a highly regarded pediatric dentist, biochemist and educator. Over 20years in dentistry, he has worked as a dental assistant, free clinic director, general dentist, pediatric dentist and scientist. He has authored orco-authored over 45 publications and taught more than 100 dental continuing education courses. He is known for introducing American dentistry to silver diamine fluoride and he

Dr. Jeannine Hoang, M.D., owner and operator of four United Dermatology Associates locations throughout North Texas discusses her mission to provide exceptional healthcare to patients of various ages, offering services in cosmetic dermatology, medical dermatology and surgical dermatology. She says that she's "intrigued by the field of preventive medicine and anti-aging and actively learning about proactive approaches to maintain health and function through healthy lifestyle habits." She is unable to treat the skin effectively without looking at the overall health of the person. Jeannine Hoang, M.D., United Dermatology Associates. An excellent high school student, Dr. Jeannine Hoang went on to graduate summa cum laude from the University of Texas at Austin. She completed medical school at Baylor College of Medicine, with an internship in Internal Medicine at Presbyterian Hospital of Dallas and a residency in Dermatology at the University of Louisville in Kentucky. She established Mansfield Dermatology in 2007

Dr. Kenyon Godwin, D.C., owner and operator of two Active Family Wellness Centers in Arlington, TX discusses his approach to healing with an effective lifestyle modification program utilizing Functional Medicine. The program incorporates the best of wellness: Chiropractic, Nutrition, Detox, Comprehensive labs, Supplements, Massage, Fitness, Mentorship and Meditation/Prayer. His goal is to make Arlington the healthiest city in Texas.\ Kenyon Godwin, D.C., Active Family Wellness Center. When Dr. Godwin was 12, his mother had a heart attack. As a single mom with no insurance, she didn’t get the help she needed. Dr. Godwin decided he wanted to be a doctor so he could help others. His anatomy teacher was a chiropractor who told stories about his office. It interested Dr. Godwin. After joining the military, he had a medical-based position that reignited his passion for health care. He decided to attend chiropractic school. Dr. Godwin went to Parker University to obtain a Doctor of Chiropractic. Since he didn’t gr

Dr. Caroline Loew, President and CEO of Glympse Bio, a clinical stage biotechnology company, discusses the company's development of tunable biosensors capable of noninvasive disease monitoring in NASH, other fibrotic diseases, and Non-Small Cell Lung Cancer. They serve as a repeatable alternative to biopsy, allowing patients to be monitored more frequently without the need for a surgical procedure. Caroline J. Loew, Ph.D., Pesident & Chief Executive Officer. Caroline is a biopharmaceutical executive with over 20 years of experience successfully leading diverse, empowered, and integrated teams. She has broad experience integrating science, business, and the clinic to deliver differentiated value to patients. Most recently, she was Vice President, Head R&D Strategy, and Planning at Bristol-Myers Squibb where she led portfolio strategy and operations. This included shaping BMS’s strategy and portfolio to deliver strong competitive positioning inmmune-oncology, immunoscience, fibrosis, and cardiovascula

Dr. Preetesh Jain, Assistant Professor, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, discusses new CALQUENCE® (acalabrutinib) data presented at ASH 2020 demonstrating long-term efficacy and tolerability at three years for patients with mantle cell lymphoma (MCL). Preetesh Jain MBBS, MD, DM, PhD is an Asst. Prof. in the Department of lymphoma and myeloma at University of Texas M.D. Anderson Cancer Ctr., Houston, TX USA. Dr. Jain has received his medical degree from India and completed at 3 year residency and 3 year medical oncology fellowship at Tata Memorial Hospital in Mumbai India. Dr. Jain moved to US in 2008, completed his PhD in molecular medicine at Feinstein Institute for medical research on IL-17 in CLL micro-environment. He then completed a 2 year clinical fellowship and leukemia Department at University of Texas M.D. Anderson Cancer Center. Then he repeated a 3 year residency in internal medicine at University of Texas Houston, then he repeated a three-year med

Returning guest, Dr. David Spetzler, President and Chief Scientific Officer and Dr. Jim Abraham, Senior Vice President and Chief Data Officer at Caris Life Sciences discuss positive results from validation studies of MI FOLFOXai™, Caris Life Sciences’ artificial intelligence (AI)-based predictor that gauges a metastatic colorectal cancer (mCRC) patient’s likelihood of benefiting from the sequence of two first-line, standard of care treatments. These results were published in "Clinical Cancer Research" a publication of the "American Association for Cancer Research". David Spetzler, MS, Ph.D., MBA, President and Chief Scientific Officer. Dr. Spetzler joined Caris Life Sciences® in August of 2009 and has held several management positions with increasing responsibilities during his tenure. He leads the company’s clinical testing service and development of proprietary technologies to aid in the creation of precision medicine strategies for individual cancer patients and noninvasive technologies to identify and p

Returned guest, Kent Thoelke, Chief Scientific Officer and Executive Vice President at PRA Health Sciences, a leading pharmaceutical service, healthcare data, and contract research provider discusses decentralized and virtual clinical trials and the impact on the future of pharmaceuticals. Kent Thoelke is the Chief Scientific Officer and Executive Vice President of PRA Health Sciences, a global contract research organization that is focused on clinical research as a care option (CRACCO). With almost three decades in the drug development and clinical trials industry, Mr. Thoelke has had the opportunity to participate in all levels of drug research from the bench to the bedside globally. Having had the opportunity to work in biotech, pharma and the CRO industries, he brings a unique perspective based on those experiences to the modernization of clinical trials. Mr. Thoelke is an industry pioneer and leader in the space of decentralized and virtual clinical trials and the underlying technologies that support

Kent Thoelke, Chief Scientific Officer and Executive Vice President of PRA Health Sciences, a leading pharmaceutical service, healthcare data, and contract research provider discusses decentralized and virtual clinical trials, and how this technology helps in overcoming racial disparities in trials. Kent Thoelke is the Chief Scientific Officer and Executive Vice President of PRA Health Sciences, a global contract research organization that is focused on clinical research as a care option (CRACCO). With almost three decades in the drug development and clinical trials industry, Mr. Thoelke has had the opportunity to participate in all levels of drug research from the bench to the bedside globally. Having had the opportunity to work in biotech, pharma and the CRO industries, he brings a unique perspective based on those experiences to the modernization of clinical trials. Mr. Thoelke is an industry pioneer and leader in the space of decentralized and virtual clinical trials and the underlying technologies th

Dr. Richard Levitan, an airway specialist who has practiced emergency medicine for over 30 years, and co-founder and executive director of Prone2Help, a national 501c3 non-profit organization, discusses proning and how it has positively impacted patients with COVID-19, the need for proning cushions in the U.S., and how others can help support the cause. Dr. Richard Levitan was in the first class of Emergency Medicine residents at Bellevue Hospital (1990-1994), and subsequently worked in academic, high-volume, inner-city trauma hospitals in NYC and Philadelphia for 25 years (Bellevue, Lincoln, Penn, Einstein, Jefferson). Starting in 2012 he began working in rural, critical care access hospitals. He now balances this clinical activity with teaching courses, speaking engagements, and device development. In addition to the Airway Cam (1994), his inventions include the Levitan FPS optical stylet (Clarus Medical), the Control Cric (Pulmodyne Inc.), and the Universal Stylet Bougie (USB, Intersurgical Ltd.). He has

Returning guest, Dr. Richard Shane, PhD, co-founder and Chief Clinical Officer of Sleep Easy (formerly Sleep Easily) discusses the new Sleep Easy Mobile App launched in Dec 2020 that is based on his proven methodology of Neurosomatic Patterning for Sleep™. Richard Shane, Ph.D. is an internationally renown Sleep Expert featured in over 100 medical journals and publications including Men’s Journal, Shape, Dr. Oz the Good Life, Huffington Post, Reader’s Digest, International Journal for Sleeping Disorders, along with being a Sleep Expert for Psychology Today. Dr. Shane created the Sleep Easy Method, clinically-proven sleep solution based on the neurophysiology of sleep, that treats even the most challenging sleep issues. Dr. Shane works with several large medical groups serving over 300,000 patients and has worked with large-scale organizations including the U.S. Military, Oil & Gas Industry, Commercial Airlines, Municipalities and Police & Fire Departments and many more. Dr. Shane is on a mission to tr